TLSI
TriSalus Life Sciences, Inc.
NASDAQ · USHealthcareMedical - Devices
$4.31+0.47%
Price as of Jul 20, 2026
TLSI capital
TriSalus Life Sciences, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 2.69x
- Net debt / equity
- -1.72x
- Debt / assets
- 0.49x
- Debt / EBITDA
- -1.65x
- Net debt / EBITDA
- 1.05x
Liquidity & coverage
- Current ratio
- 5.78x
- Quick ratio
- 5.46x
- Cash ratio
- 4.80x
- Interest coverage
- -4.86x
- EBITDA / interest
- -3.63x
- Working capital
- $56.4M
Cash & dividend
- FCF / debt
- -0.59x
- Cash flow / debt
- -0.58x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.